AI custom-tailors artificial DNA to future drug development
Researchers at Chalmers University of Technology in Sweden have successfully designed synthetic DNA that controls cell protein production with the aid of AI. This technology could help develop and produce vaccines, drugs to treat severe diseases and alternative food proteins at a much lower cost than currently.
The process of gene expression is essential to the functioning of all cells. The genetic code of DNA is translated into the messenger RNA molecule (mRNA), telling the cell factory what protein to make and in what quantities.
Researchers have spent a great deal of time and effort trying to control gene transcription because it, among other reasons, can help develop protein-based medicines. Recent examples include the mRNA against COVID-19 which told the cells in the body to produce the same proteins found on the surface the coronavirus.